Guaifenesin 200mg
- Product NDC
- 10135-789
- 11-digit product format
- 101350789
- Labeler code
- 10135
- Product ID
- 10135-789_437e388b-2293-0064-e063-6394a90add05
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-03-01
- Substance
- GUAIFENESIN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin 200mg
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 197741 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-789-01 | Guaifenesin 200mg | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-789 | GUAIFENESIN 200MG (GUAIFENESIN) TABLET [MARLEX PHARMACEUTICALS INC] | 1 | Current NDC, 1 package rows | 20240319_13b8f480-d1ac-d70c-e063-6394a90ab4f4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 10135-789-01 | 10135078901 | 100 TABLET in 1 BOTTLE (10135-789-01) | 100 tablet | 2024-03-01 | No | No | Historical |